Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10720)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2017 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Arslan N, Yılmaz Ö, Demiray-Gürbüz E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J Gastroenterol 2017; 23(16): 2854-2869 [PMID: 28522904 DOI: 10.3748/wjg.v23.i16.2854] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v23/i16/2854.htm |
| Number | Citing Articles |
| 1 |
Leila Lormohammadi, Farhad Nikkhahi, Shahin Bolori, Ali Akbar Karami, Sepideh Hajian, Neda Rad, Amir Peymani, Rasoul Samimi. High level of resistance to metronidazole and clarithromycin among Helicobacter pylori clinical isolates in Qazvin province, Iran. Gene Reports 2022; 26: 101494 doi: 10.1016/j.genrep.2022.101494
|
| 2 |
Masoud Keikha, Mohsen Karbalaei. Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis. Microbial Pathogenesis 2022; 170: 105720 doi: 10.1016/j.micpath.2022.105720
|
| 3 |
Mehrdad Moosazadeh Moghaddam, Shahin Bolouri, Reza Golmohammadi, Mahdi Fasihi-Ramandi, Mohammad Heiat, Reza Mirnejad. Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles. Journal of Materials Science: Materials in Medicine 2023; 34(9) doi: 10.1007/s10856-023-06748-w
|
| 4 |
Sho Suzuki, Mitsuru Esaki, Chika Kusano, Hisatomo Ikehara, Takuji Gotoda. Development of <i>Helicobacter pylori</i> treatment: How do we manage antimicrobial resistance?. World Journal of Gastroenterology 2019; 25(16): 1907-1912 doi: 10.3748/wjg.v25.i16.1907
|
| 5 |
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik. Current Status of the Third-LineHelicobacter pyloriEradication. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6523653
|
| 6 |
Yan Zhao, Yang Li, Zhixian Luan, Cuiping Ma, Lin Yang, Wang Zhang, Chao Shi. Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection. Journal of Microbiological Methods 2022; 192: 106393 doi: 10.1016/j.mimet.2021.106393
|
| 7 |
Juan Bueno. Preclinical Evaluation of Antimicrobial Nanodrugs. Nanotechnology in the Life Sciences 2020; : 1 doi: 10.1007/978-3-030-43855-5_1
|
| 8 |
Helia Alavifard, Ali Nabavi-Rad, Kaveh Baghaei, Amir Sadeghi, Abbas Yadegar, Mohammad Reza Zali. Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates. BMC Research Notes 2023; 16(1) doi: 10.1186/s13104-023-06420-0
|
| 9 |
Xueping Huang, Baihe Wu, Qiuzhao Chen, Yushan Chen, Xinhua Ji, Xiang Zhou, Biao Suo, Zhihui Lin, Xiaoling Zheng. Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China. PeerJ 2023; 11: e15611 doi: 10.7717/peerj.15611
|
| 10 |
Mohammad Zamani, Arash Rahbar, Javad Shokri-Shirvani. Resistance of <i>Helicobacter pylori</i> to furazolidone and levofloxacin: A viewpoint. World Journal of Gastroenterology 2017; 23(37): 6920-6922 doi: 10.3748/wjg.v23.i37.6920
|
| 11 |
Lok Ka Lam, Ka Shing Cheung. Towards the Eradication of Helicobacter pylori Infection - Rapid Diagnosis and Precision Treatment. 2024; doi: 10.5772/intechopen.1004378
|
| 12 |
Nilanjana Das, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal. Probiotics in the Prevention and Management of Human Diseases. 2022; : 281 doi: 10.1016/B978-0-12-823733-5.00001-5
|
| 13 |
Ahmed Megahed Abouwarda, Tarek Abdelmonem Ismail, Wael Mohamed Abu El-Wafa, Ahmed Hassan Ibrahim Faraag. Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori. World Journal of Microbiology and Biotechnology 2022; 38(6) doi: 10.1007/s11274-022-03289-2
|
| 14 |
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
|
| 15 |
Nuzhat Qureshi, Ping Li, Qing Gu. Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?. Applied Microbiology and Biotechnology 2019; 103(4): 1573 doi: 10.1007/s00253-018-09580-3
|
| 16 |
Jianping Cheng, Chanjuan Fan, Kun Huang, Lili Zhai, Hui Wang, Dongling Xie, Yong Cai, Zhen Li, Qixuan Bai, Pan Wang, Haiou Ding. Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1272744
|
| 17 |
Helia Alavifard, Nasrin Mirzaei, Abbas Yadegar, Kaveh Baghaei, Sinéad Marian Smith, Amir Sadeghi, Mohammad Reza Zali. Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study. Current Microbiology 2021; 78(1): 244 doi: 10.1007/s00284-020-02295-7
|
| 18 |
Luis Fernando Valladales-Restrepo, Yessenia Correa-Sánchez, Brayan Stiven Aristizábal-Carmona, Jorge Enrique Machado-Alba. Treatment regimens used in the management of Helicobacter pylori in Colombia. The Brazilian Journal of Infectious Diseases 2022; 26(1): 102331 doi: 10.1016/j.bjid.2022.102331
|
| 19 |
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategies. Critical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
|
| 20 |
Jonathon P Schubert, Jessica Gehlert, Christopher K Rayner, Ian C Roberts‐Thomson, Sam Costello, Arduino A Mangoni, Robert V Bryant. Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(6): 1450 doi: 10.1111/jgh.15352
|
| 21 |
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?. Revista de Gastroenterología de México (English Edition) 2022; 87(3): 330 doi: 10.1016/j.rgmxen.2022.06.003
|
| 22 |
Fatih Buyuk, Emre Karakaya, Mustafa Akar, Tuba Kayman, Serdal Tarhane, Hacer Ece Ozcan, Ozgur Celebi, Izzet Burcin Saticioglu, Turgut Anuk, Secil Abay, Salih Otlu, Fuat Aydin. A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination. Antonie van Leeuwenhoek 2023; 116(12): 1261 doi: 10.1007/s10482-023-01868-3
|
| 23 |
Lou Yu, Laisheng Luo, Xiaohua Long, Xiao Liang, Yingjie Ji, Qi Chen, Yanyan Song, Xiaobo Li, David Y. Graham, Hong Lu. Susceptibility-guided therapy for Helicobacter pylori infection treatment failures. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819874922
|
| 24 |
Zerihun Feyissa, Gemechu Deressa Edossa, Neeraj Kumar Gupta, Defaru Negera. Development of double crosslinked sodium alginate/chitosan based hydrogels for controlled release of metronidazole and its antibacterial activity. Heliyon 2023; 9(9): e20144 doi: 10.1016/j.heliyon.2023.e20144
|
| 25 |
Judit Alarcón-Millán, José Bonilla-Delgado, Gloria Fernández-Tilapa, Nayeli Goreti Nieto-Velázquez, Mónica Sierra-Martínez, Víctor Manuel Alvarado-Castro, Enoc Mariano Cortés-Malagón. Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens 2023; 12(2): 234 doi: 10.3390/pathogens12020234
|
| 26 |
Ying‐Ying Han, Hui Long, Ya Lin, Qiong He, Wei‐Gang Chen, Xiang‐Wu Ding, Lin Zhou, Ping An, Fen Wang, Zhen‐Yu Zhang, Yun‐Lian Hu, Pei‐Yuan Li. Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study. Helicobacter 2022; 27(5) doi: 10.1111/hel.12922
|
| 27 |
Behtash G. Nezami, Mehul Jani, David Alouani, Daniel D. Rhoads, Navid Sadri, Andrew B. Onderdonk. Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment Failure. Journal of Clinical Microbiology 2019; 57(7) doi: 10.1128/JCM.01834-18
|
| 28 |
Aalaa Mahgoub Albasha, Maram M. Elnosh, Esraa Hassan Osman, Duha M. Zeinalabdin, Amira A. M. Fadl, Musa Abdalla Ali, Hisham N. Altayb. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients. BMC Microbiology 2021; 21(1) doi: 10.1186/s12866-021-02096-3
|
| 29 |
Éva Kocsmár, György Miklós Buzás, Ildikó Szirtes, Ildikó Kocsmár, Zsófia Kramer, Attila Szijártó, Petra Fadgyas-Freyler, Kató Szénás, Massimo Rugge, Matteo Fassan, András Kiss, Zsuzsa Schaff, Gergely Röst, Gábor Lotz. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-22557-7
|
| 30 |
Fumiaki Ishibashi, Sho Suzuki, Mizuki Nagai, Kentaro Mochida, Tetsuo Morishita. Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments. Gut and Liver 2023; 17(5): 684 doi: 10.5009/gnl220429
|
| 31 |
Yue Tong, Ruoyu Dang, Yongmei Yin, Changjun Men, Rimo Xi. A whole genome sequencing-based assay to investigate antibiotic susceptibility and strain lineage of Helicobacter pylori. Microbial Pathogenesis 2024; 197: 107069 doi: 10.1016/j.micpath.2024.107069
|
| 32 |
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Neng-Sheng Chu, Pei-Yun Tsai, Ping-I Hsu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Fang-Jung Yu, Chao-Hung Kuo. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. Journal of the Formosan Medical Association 2022; 121(8): 1450 doi: 10.1016/j.jfma.2021.10.011
|
| 33 |
Denise Brennan, Colm O’Morain, Deirdre McNamara, Sinéad M. Smith. Helicobacter Pylori. Methods in Molecular Biology 2021; 2283: 29 doi: 10.1007/978-1-0716-1302-3_4
|
| 34 |
Rongli Cui, Zhiqiang Song, Baojun Suo, Xueli Tian, Yan Xue, Lingmei Meng, Zhanyue Niu, Zhu Jin, Hejun Zhang, Liya Zhou. Correlation Analysis Among Genotype Resistance, Phenotype Resistance and Eradication Effect of Helicobacter pylori. Infection and Drug Resistance 2021; : 1747 doi: 10.2147/IDR.S305996
|
| 35 |
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?. Revista de Gastroenterología de México 2022; 87(3): 330 doi: 10.1016/j.rgmx.2022.01.007
|
| 36 |
Chao Ran Ji, Jing Liu, Yue Yue Li, Chen Qiao, Jun Yan Qu, Jun Nan Hu, Min Juan Lin, Rui Ji, Li Xiang Li, Xiu Li Zuo, Yan Qing Li. Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial. Journal of Digestive Diseases 2020; 21(10): 549 doi: 10.1111/1751-2980.12934
|
| 37 |
Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALHAES, Décio CHINZON, Marcelo CURY, Gerson DOMINGUES, Jorge Luiz JORGE, Ismael MAGUILNIK, Frederico Passos MARINHO, Joaquim Prado de MORAES-FILHO, José Miguel Luz PARENTE, Celso Mirra de PAULA-E-SILVA, José PEDRAZZOLI-JÚNIOR, Ana Flávia Passos RAMOS, Heinrich SEIDLER, José Nonato SPINELLI, José Vitor ZIR. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arquivos de Gastroenterologia 2018; 55(2): 97 doi: 10.1590/s0004-2803.201800000-20
|
| 38 |
Azizollah Yousefi, Shahryar Eslami, Samileh Noorbakhsh, Morteza Haghighi, Leila TaheriNia, Fahimeh Ehsanipour, Sarvenaz Ashouri. The Resistance Rate of Helicobacter Pylori to Clarithromycin and Main Mutations on Bacterial Genomic Responsible for Bacterial Resistance: A Comparative Study in Children and Adults, Tehran and Iran. Infectious Disorders - Drug Targets 2019; 19(4): 394 doi: 10.2174/1871526518666181012113052
|
| 39 |
Chih-Ming Liang, Wei-Chen Tai, Pin-I Hsu, Deng-Chyang Wu, Chao-Hung Kuo, Feng-Woey Tsay, Chia-Long Lee, Kuan-Yang Chen, Seng-Kee Chuah. Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820976990
|
| 40 |
Takuji Gotoda, Chika Kusano, Sho Suzuki, Toshiki Horii, Ryoji Ichijima, Hisatomo Ikehara. Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan. Journal of Gastroenterology 2020; 55(10): 969 doi: 10.1007/s00535-020-01709-4
|
| 41 |
Javier Casado, Irene Olivan-Muro, Sonia Algarate, Eduardo Chueca, Sandra Salillas, Adrián Velázquez-Campoy, Elena Piazuelo, María F. Fillat, Javier Sancho, Ángel Lanas, Andrés González. Novel Drug-like HsrA Inhibitors Exhibit Potent Narrow-Spectrum Antimicrobial Activities against Helicobacter pylori. International Journal of Molecular Sciences 2024; 25(18): 10175 doi: 10.3390/ijms251810175
|
| 42 |
Javier P. Gisbert. Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820968736
|
| 43 |
Jing‐Jing Zhou, Xiao Shi, Shao‐Peng Zheng, Dan Tang, Ting Cai, Yao Yao, Fen Wang. Efficacy of bismuth‐based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large‐scale prospective, single‐center clinical trial in China. Helicobacter 2020; 25(6) doi: 10.1111/hel.12755
|
| 44 |
Zerihun Feyissa, Gemechu Deressa Edossa, Tariku Bayisa Bedasa, Leta Guta Inki, Qinglin Wu. Fabrication of pH-Responsive Chitosan/Polyvinylpyrrolidone Hydrogels for Controlled Release of Metronidazole and Antibacterial Properties. International Journal of Polymer Science 2023; 2023: 1 doi: 10.1155/2023/1205092
|
| 45 |
Guofeng Yin, Shuxian Bie, Hongdan Gu, Xiaoli Shu, Wei Zheng, Kerong Peng, Hong Zhao, Fubang Li, Bo Chen, Benson O A Botchway, Marong Fang, Mizu Jiang. Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children. Journal of Gastroenterology and Hepatology 2020; 35(8): 1331 doi: 10.1111/jgh.14980
|
| 46 |
Thanh Binh Vu, Thi Nhu Quynh Tran, Thi Quynh Anh Tran, Dinh Luong Vu, Van Thuan Hoang. Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer. Medicina 2022; 59(1): 6 doi: 10.3390/medicina59010006
|
| 47 |
Han-Yi Song, Long Zhou, Dong-yan Liu, Xin-Jie Yao, Yan Li. What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9379480
|
| 48 |
Te-Fu Lin, Ping-I Hsu. Second-line rescue treatment of <i>Helicobacter pylori</i> infection: Where are we now?. World Journal of Gastroenterology 2018; 24(40): 4548-4553 doi: 10.3748/wjg.v24.i40.4548
|
| 49 |
Bea Van den Poel, Sarah Gils, Isabel Micalessi, Saskia Carton, Paul Christiaens, Pieter-Jan Cuyle, Veerle Moons, Gust Van Olmen, Annick Smismans, Claire Bourgain, Peter Bossuyt, Johan Frans. Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assay. Acta Clinica Belgica 2021; 76(3): 177 doi: 10.1080/17843286.2019.1685741
|
| 50 |
Sabrina Grando Cordeiro, Rafaela Ziem, Ytan Andreine Schweizer, Bruna Costa, Daniel Kuhn, Peterson Haas, Ani Caroline Weber, Daiane Heidrich, Eduardo Miranda Ethur, Clarice Steffens, Lucélia Hoehne. Degradation of micropollutant cephalexin by ultraviolet (UV) and assessment of residual antimicrobial activity of transformation products. Water Science and Technology 2021; 84(2): 374 doi: 10.2166/wst.2021.170
|
| 51 |
Sho Suzuki, Takuji Gotoda, Chika Kusano, Hisatomo Ikehara, Ryoji Ichijima, Motoki Ohyauchi, Hirotaka Ito, Masashi Kawamura, Yohei Ogata, Masahiko Ohtaka, Moriyasu Nakahara, Koichi Kawabe. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-lineHelicobacter pyloritreatment: a multicentre randomised trial in Japan. Gut 2020; 69(6): 1019 doi: 10.1136/gutjnl-2019-319954
|
| 52 |
Evelyn Pedroso Toscano, Fernanda Fernandes Madeira, Mayra Pinheiro Dutra-Rulli, Luiz Otavio Maia Gonçalves, Marcela Alcântara Proença, Viviane Silva Borghi, Aline Cristina Targa Cadamuro, Giselda Warick Mazzale, Ricardo Acayaba, Ana Elizabete Silva. Epidemiological and Clinical-Pathological Aspects of Helicobacter pylori Infection in Brazilian Children and Adults. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/8454125
|
| 53 |
Menizibeya Osain Welcome. Gastrointestinal Physiology. 2018; : 991 doi: 10.1007/978-3-319-91056-7_14
|
| 54 |
Samantha Flores-Treviño, Soraya Mendoza-Olazarán, Paola Bocanegra-Ibarias, Héctor Jesús Maldonado-Garza, Elvira Garza-González. Helicobacter pyloridrug resistance: therapy changes and challenges. Expert Review of Gastroenterology & Hepatology 2018; 12(8): 819 doi: 10.1080/17474124.2018.1496017
|
| 55 |
Tian Geng, Zhong-Su Yu, Xi-Xi Zhou, Bo Liu, Hui-Hua Zhang, Zhong-Yue Li. Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China. European Journal of Pediatrics 2022; 181(7): 2715 doi: 10.1007/s00431-022-04456-1
|
| 56 |
Nader Nemr, Rania M. Kishk, Ayman Salem, Mohamed O. Abdalla, Noha M. Abd El-Fadeal, Nashaat M. Soliman. Genotypic detection of metronidazole and clarithromycin resistance in dyspeptic patients with helicobacter pylori. Environmental Science and Pollution Research 2022; 29(27): 41467 doi: 10.1007/s11356-021-18198-4
|
| 57 |
Ho-Yu Ng, Wai K. Leung, Ka-Shing Cheung. Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection. International Journal of Molecular Sciences 2023; 24(14): 11708 doi: 10.3390/ijms241411708
|
| 58 |
Tzu-Hsin Huang, Shih-Cheng Yang, Wei-Chen Tai, Chih-Ming Liang, Chung-Mou Kuo, Chih-Chien Yao, Cheng-Kun Wu, Yuan-Hung Kuo, Yeh-Pin Chou, Chen-Hsiang Lee, Keng-Liang Wu, Seng-Kee Chuah. The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance. Biomedical Journal 2021; 44(6): S275 doi: 10.1016/j.bj.2020.11.012
|
| 59 |
Ying-Ying Han, Lin Zhou, Yun-Lian Hu, Xiang-Wu Ding, Hui Long, Fei Liu, Ming Xu, Zhen-Yu Zhang, Shuang-Ling Li, Qiu-Yan Wang, Cheng-Xia Su, Yan Chen, Jie Chen, Ya Lin, Pei-Yuan Li. Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study. Journal of Gastroenterology 2023; 58(12): 1167 doi: 10.1007/s00535-023-02042-2
|
| 60 |
Irina Yurievna Kolesnikova, Irina Vyacheslavovna Ivakhnenko, Anzhelika Viktorovna Ponomareva, Sergey Ivanovich Krayushkin. Modern aspects of eradication therapy. Spravočnik vrača obŝej praktiki (Journal of Family Medicine) 2020; (12): 36 doi: 10.33920/med-10-2012-05
|
| 61 |
Olga P. Nyssen, Marta Espada, Javier P. Gisbert. Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.913436
|
| 62 |
Vladimir Milivojević, Miodrag Krstić, Branislava Medić-Brkić. Influence of antibiotic resistance in the treatment of Helicobacter pylori infection. Medicinski podmladak 2023; 74(2): 7 doi: 10.5937/mp74-41665
|
| 63 |
Jonathon P. Schubert, Paul R. Ingram, Morgyn S. Warner, Christopher K. Rayner, Ian C. Roberts‐Thomson, Samuel P. Costello, Robert V. Bryant. Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance. Internal Medicine Journal 2023; 53(11): 1972 doi: 10.1111/imj.16226
|
| 64 |
Feiyang Zheng, Kang Wang, Qianning Wang, Tiantian Yu, Xinping Zhang. The pre-analytical process management status and influencing factors of laboratory test before prescribing antimicrobial in developing country. BMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09243-8
|
| 65 |
Jina Vazirzadeh, Jamal Falahi, Sharareh Moghim, Tahmineh Narimani, Rahmatollah Rafiei, Vajihe Karbasizadeh. Molecular Assessment of Resistance to Clarithromycin in Helicobacter pylori Strains Isolated from Patients with Dyspepsia by Fluorescent In Situ Hybridization in the Center of Iran. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2304173
|
| 66 |
Alexander Vanden Bulcke, Bruno Waked, Lise Haems, Guy Lambrecht, Anne-Sophie Hervent, Gudrun Alliet, Filip Baert, Steven Vervaeke. Antimicrobial resistance of Helicobacter pylori in West Flanders – Belgium: an observational cross-sectional study. Acta Clinica Belgica 2022; 77(2): 360 doi: 10.1080/17843286.2021.1872307
|
| 67 |
Enrico Celestino Nista, Antonio Pellegrino, Lucia Giuli, Marcello Candelli, Tommaso Schepis, Sara Sofia De Lucia, Veronica Ojetti, Francesco Franceschi, Antonio Gasbarrini. Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature. Antibiotics 2022; 11(10): 1452 doi: 10.3390/antibiotics11101452
|
| 68 |
Catarina Correia, Nuno Almeida, Carina Leal, Diogo Branquinho, Alexandra Fernandes, Elisa Gravito-Soares, Carlos Calhau, Isabel Bastos, Helena Vasconcelos, Pedro Figueiredo. Single-capsule bismuth-based quadruple therapy as a rescue therapy for Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology 2023; 58(3): 227 doi: 10.1080/00365521.2022.2119097
|
| 69 |
Chang Seok Bang, Hyun Lim, Hae Min Jeong, Woon Geon Shin, Jae Ho Choi, Jae Seung Soh, Ho Suk Kang, Young Joo Yang, Ji Taek Hong, Suk Pyo Shin, Ki Tae Suk, Jae Jun Lee, Gwang Ho Baik, Dong Joon Kim. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection. Gut Microbes 2020; 11(5): 1314 doi: 10.1080/19490976.2020.1754118
|
| 70 |
Reza Ranjbar, Amir Ebrahimi, Amirhossein Sahebkar. Helicobacter pylori Infection: Conventional and Molecular Strategies for
Bacterial Diagnosis and Antibiotic Resistance Testing. Current Pharmaceutical Biotechnology 2023; 24(5): 647 doi: 10.2174/1389201023666220920094342
|
| 71 |
Agnes Tving Stauning, Rie Louise Møller Nordestgaard, Tove Havnhøj Frandsen, Leif Percival Andersen. Helicobacter pylori [Working Title]. 2018; doi: 10.5772/intechopen.80662
|
| 72 |
Ranjot Kaur, Carlos Leon Guevara. Addressing Challenges in Standardizing Helicobacter pylori Treatment Protocols: Importance and Review. Cureus 2024; doi: 10.7759/cureus.59394
|